Kenfarb & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Kenfarb & Co’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$128K	Hold	874	–	–	0.12%	116
2023 Q2	$134K	Hold	874	–	–	0.12%	117
2023 Q1	$135K	Hold	874	–	–	0.12%	115
2022 Q4	$135K	Hold	874	–	–	0.12%	115
2022 Q3	$115K	Hold	874	–	–	0.11%	116
2022 Q2	$130K	Hold	874	–	–	0.1%	116
2022 Q1	$130K	Hold	874	–	–	0.1%	116
2021 Q4	$142K	Buy	+874	New	+$141K	0.1%	113

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Kenfarb & Co's FBT Position: Q3 2023 in Review

Kenfarb & Co held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2023 at 874 shares worth $128K. The position accounts for 0.12% of the portfolio, ranked #116.

Kenfarb & Co first reported a position in FBT in Q4 2021 and has held it in 8 quarters since. The position peaked at $142K in Q4 2021. 242 funds tracked by Wall St. Rank hold FBT as of Q3 2023.

Kenfarb & Co held 874 shares of First Trust NYSE Arca Biotechnology Index Fund worth $128K as of Q3 2023.
Kenfarb & Co left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2023.
First Trust NYSE Arca Biotechnology Index Fund made up 0.12% of Kenfarb & Co's portfolio in Q3 2023, its #116 holding.
Kenfarb & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $142K in Q4 2021.
242 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.